Molecular pathogenesis of Friedreich ataxia

Archives of Neurology

Volumn 56, Issue 10, 1999, Pages 1201-1208

  Pandolfo, Massimo ^a  

^a CENTRE HOSPITALIER DE L UNIVERSITÉ DE MONTRÉAL   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

FRATAXIN; FREE RADICAL; IRON;

AUTOSOMAL RECESSIVE INHERITANCE; BRAIN MITOCHONDRION; CELL SPECIFICITY; CELLULAR DISTRIBUTION; FRIEDREICH ATAXIA; HUMAN; IRON METABOLISM; MISSENSE MUTATION; NONSENSE MUTATION; OXIDATIVE STRESS; PRIORITY JOURNAL; PROTEIN LOCALIZATION; REVIEW;

EID: 0032863136     PISSN: 00039942     EISSN: None     Source Type: Journal    
DOI: 10.1001/archneur.56.10.1201     Document Type: Review

References (77)

1. Skie H. Fiiedreich's ataxia in Western Norway. Clin Genet. 1975:7:287-298.
2. Romeo G, Menozzi P, Ferlini A, et al. Incidence of Friedreich ataxia in Italy estimated from consanguinous marriages. Am J Hum Genet. 1983:35:523-529.
3. Haiding AE. Classification of the hereditary ataxias and paraplegias. Lancet. 1983; 1:1151-1155.
4. Leone M, Erignolio F, Rosso MG, et al. Friedreich's ataxia: a descriptive epidemiological study in an Italian population. Clin Genet. 1990:38:161-169.
5. Bouchaid JP, Bai beau A, Bouchard R, Paquet M, Bouchard RW. A cluster of Friedreich's ataxia in Rimouski, Quebec. CanJNeutol Sei. 1979:6:205-208.
6. Dean G, Chainbeilain S, Middieton L. Fiiedreich's ataxia in Kathikas-Arodhes, Cypius [leitet]. Lancet. 19S8,1:587.
7. Fricdieich IJ Über degenerative Atrophie der spinalen Hinterstränge. Virchows Arch Pathol Anat. 1803:27:1-26.
8. Fiiedieich N. Über degenerative Atrophie der spinalen Hinterstränge. Virchous Arch PatholAnat. 1863:27:391-419.
9. Ftiedreich N. Über degenerative Atrophie der spinalen Hinterstränge. Virchows Arch PatholAnat. 1863:27:433-459.
10. Friedreich N. Über ataxie mit besonderer berücksichtigung der hereditären formen. Vitchows Arch PatholAnat. 1876:68:145-245.
11. Fiiedreich N. Über ataxie mit besonderer berücksichtigung der hereditären formen. Virchov.'s Arch Pathol Anat. 1377:70:140-142.
12. Geoffroy G, Barbeau A, Breton G, et al. Clinical description and roentgenologic evaluation of patients with Fiiedreich ataxia. Can JNeurol Sei. 1976:3:279-286.
13. Haiduig AE. Fiiedieich's ataxia: a clinical and genetic study of 90 families with an analysis of eaily diagnosis criteria and intrafarmlial clustering of clinical featuies. fta/n. 1981:104.589-620.
14. Barbeau A, Roy M, Sadibelouiz M, Wilensky MA. Recessive ataxia in Acadians and "Cajuns." Can J Neurol Sei. 1984:11:526-533.
15. Richter A, Poirier J, Mercier J, et al. Friedreich ataxia in Acadian families from eastern Canada: clinical diversity with conserved haplotypes. Am J Med Genet. 1996:64:594-601.
16. Klockgether T, Chamberlain S, Wullner U, et al. Late-onset Friedreich's ataxia: molecular genetics, clinical neurophysiology, and magnetic resonance imaging. Arch Neurol 1993:50:803-806.
17. De Michele G, Filla A, Cavalcanti F, et al. Late onset Friedreich's disease: clinical features and mapping of mutation to the FRDA locus. J Neurol Neurosurg Psychiatry. 1994:57:977-979.
18. Palau F, De Michele G, Vilchez JJ, et al. Early-onset ataxia with cardiomyopathy and retained tendon reflexes maps to Friedreich's ataxia locus on chromosome 9q. Ann Neurol. 1997:37:359-362.
19. Chamberlain S, Shaw J, Rowland A, et al. Mapping of mutation causing Friedreich ataxia to human chromosome 9. Nature. 1988:334:248-250.
20. Fujita R, Agid Y, Trouillas P, et al. Confirmation of linkage of Friedreich ataxia to chromosome 9 and identification of a new closely linked marker. Genomics. 1989; 4:110-111.
21. Fujita R, Hanauer A, Sirugo G, Heilig R, Mandel JL. Additional polymorphisms at marker loci D9S5 and D9S15 generate extended haplotypes in linkage disequilibrium with Friedreich ataxia. Proc fJatl Acad Sei U S A. 1990:87:1796-1800.
22. Chamberlain S, Farrall M, Shaw J, et al. Genetic recombination events which position the Friedreich ataxia locus proximal to the D9S15/D9S5 linkage group on chromosome 9q. Am J Hum Genet. 1993:52:99-109.
23. Rodius F, Duclos F, Wrogemann K, et al. Recombinations in individuals homozygous by descent localize the Friedreich ataxia locus in a cloned 450-kb interval. Am J Hum Genet. 1994:54:1050-1059.
24. Duclos F, Rodius F, Wrogemann K, Mandel JL, Koenig M. The Friedreich ataxia region: characterization of too novel genes and reduction of the critical region to 300 kb.Wum Mol Genet. 1994:3:909-914.
25. Montermini L, Rodius F, Pianese L, et al. The Friedreich ataxia critical region spans a 150-kb interval on chromosome QqW.AmJHum Genet. 1995:57:1061-1067.
26. Campuzano V, Montermini L, Moltó MD, et al. Friedreich ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion. Science. 1996; 271:1423-1427.
27. Jiralerspong S, Liu Y, Montermini L, Stifani S, Pandolfo M. Frataxin shows developmentally regulated tissue-specific expression in the mouse embryo. NeuroWo/D/s. 1997;4:103-113.
28. Koutnikova H, Campuzano V, Foury F, Dolle P, Cazzalini 0, Koenig M. Studies of human, mouse and yeast homologues indicate a mitochondrial function for frataxin. Nat Genet. 1997;16:345-351.
29. Pianese L, Cavalcanti F, De Michele G, et al. The effect of parental gender on the GAA dynamic mutation in the FRDA gene. Am J Hum Genet. 1997:60:463-466.
30. Montermini L, Richter A, Morgan K, et al. Phenotypic variability in Friedreich ataxia: role of the associated GAA triplet repeat expansion. Ann Neurol. 1997:41:675-682.
31. Montermini L, Kish SJ, Jiralerspong S, Lamarche JB, Pandolfo M. Somatic mosaicism for the Friedreich's ataxia GAA triplet repeat expansions in the central nervous system. Neurology. 1997;49:606-610.
32. Montermini L, Andermann E, Richter A, et al. The Friedreich ataxia GAA triplet repeat: premutation and normal alleles. Hum Mol Genet. 1997:6:1261-1266.
33. Cossée M, Schmitt M, Campuzano V, et al. Evolution of the Friedreich's ataxia trinucleotide repeat expansion: founder effect and premutations. Proc fJatlAcad Sei U SA. 1997:94:7452-7457.
34. Monros E, Molto MD, Martinez F, et al. Phenotype correlation and intergenerational dynamics of the Friedreich ataxia GAA trinucleotide repeat. Am J Hum Genet. 1997:61:101-110.
35. Cossée M, Campuzano V, Koutnikova H, et al. Frataxin fracas. Nat Genet. 1997; 15:337-338.
36. Campuzano V, Montermini L, Lutz Y, et al. Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes. Hum Mol Genet. 1997; 6:1771-1780.
37. Ohshima K, Montermini L, Wells RD, Pandolfo M. Inhibitory effects of expanded GAA TTC triplet repeats from intron I of the Friedreich ataxia gene on transcription and replication in vivo. JBiolChem. 1998:273:14588-14595.
38. Wells RD, Collier DA, Hanvey JC, Shimizu M, Wohlrab F. The chemistry and biology of unusual DNA structures adopted by oligopurine-oligopyrimidine sequences. FASEB J. 1988:2:2939-2949.
39. Htun H, Dahlberg JE. Topology and formation of triple-stranded H-DNA. Sown?. 1989:243:1571-1576.
40. Ohshima K, Kang S, Larson JE, Wells RD. Cloning, characterization and properties of seven triplet repeat DMA sequences. JBiolChem. 1996:271:16773-16783.
41. Sakamoto N, Chastain PD, Parniewski P, et al. Sticky DNA: self-association properties of long GAA TCC repeats in R.R.Y triplex structures from Friedreich's ataxia. Mol Cell. 1999:3:465-475.
42. Duval-ValentinGJhuongNG, Hélène C. Specific inhibition of transcription by triplehelix forming oligonucleotides. Proc NatlAcad Sei U S A. 1992:89:504-508.
43. Imbert G, Kretz C, Johnson K, Mandel JL. Origin of the expansion mutation in myotonic dystrophy. Nat Genet. 1993:4:72-76.
44. Filla A, De Michele G, Cavalcanti F, et al. The relationship between trinucleotide (GAA) repeat length and clinical features in Friedreich ataxia. Am J Hum Genet. 1996:59:554-560.
45. Dürr A, Cessée M, Agid Y, et al. Clinical and genetic abnormalities in patients with Friedreich's ataxia. NEnglJMed. 1996:335:1169-1175.
46. Lamont PJ, Davis MB, Wood NW. Identification and sizing of the GAA trinucleotide repeat expansion of Friedreich's ataxia in 56 patients: clinical and genetic correlates. Brain. 1997:120:673-680.
47. Schols L, Amoiridis G, Przuntek H, Frank G, Epplen JT, Epplen C. Friedreich's ataxia: revision of the phenotype according to molecular genetics. Brain. 1997; 120:2131-2140.
48. Geschwind DH, Perlman S, Grody W, et al. The Friedreich's ataxia GAA repeat expansion in patients with recessive or sporadic ataxia. Neurology. 1997;49: 1004-1009.
49. Gellera C, Pareyson D, Castellotti B, et al. Very late onset Friedreich's ataxia without cardiomyopathy is associated with limited GAA expansion in the X25 gene. Neurology. 1997:49:1153-1155.
50. Berciano J, Combarros 0, De Castro M, Palau F. Intronic GAA triplet repeat expansion in Friedreich's ataxia presenting with pure sensory ataxia. JNeurol. 1997; 244:390-391.
51. Hanna MG, Davis MB, Sweeney MG, et al. Generalized chorea in too patients harboring the Friedreich's ataxia gene trinucleotide repeat expansion. Mov Disord. 1998:13:339-340.
52. Moseley ML, Benzow KA, Schuf LJ, et al. Incidence of dominant spinocerebellar and Friedreich triplet repeats among 361 ataxia families. Neurology. 1998;51: 1666-1671.
53. Bidichandani SI, Ashizawa T, Patel PI. Atypical Friedreich ataxia caused by compound heterozygosity for a novel missense mutation and the GAA triplet-repeat expansion. Am J Hum Genet. 1997;60:1251 -1256.
54. Cossée M, Dürr A, Schmitt M, et al. Friedrich's ataxia: point mutations and clinical presentation of compound heterozygotes. Ann Neurol. 1999:45:200-206.
55. Kostrzewa M, Klockgether T, Damian MS, Müller U. Locus heterogeneity in Friedreich ataxia. fJeurogenetics. 1997;1:43-47.
56. Babcock R, de Suva D, Oaks R, et al. Characterization of YFH1, a yeast gene that regulates mitochondrial iron accumulation and is homologous to the Friedreich's ataxia gene. Science. 1997:276:1709-1712.
57. Koutnikova H, Campuzano V, Koenig M. Maturation of wild-type and mutated frataxin by the mitochondrial processing peptidase. Hum Mol Genet. 1998;7: 1485-1489.
58. Knight SA, Sepuri NB, Pain D, Dancis A. Mt-Hsp70 homolog, Ssc2p, required for maturation of yeast frataxin and mitochondrial iron homeostasis. JBiolChem. 1998:273:18389-18393.
59. Wilson RB, Roof DM. Respiratory deficiency due to loss of mitochondrial DNA in yeast lacking the frataxin homologue. Nat Genet. 1997:16:352-357.
60. Lamarche JB, Shapcott D, Côté M, Lemieux B. Cardiac iron deposits in Friedreich's ataxia. In: Lechtenberg R, ed. Handbook of Cerebellar Diseases. New York, NY: Marcel Dekker; 1993:453-458.
61. Waldvogel D, van Gelderen P, Hallet M. Increased iron in the dentate nucleus of patients with Friedreich's ataxia. Ann Neurol. 1999;46:123-125.
62. Barbeau A. Friedreich's disease 1982: etiologic hypotheses a personal analysis. Can J Neurol Sei. 1982:9:243-263.
63. Rötig A, deLonlay P, Chrétien D, et al. Frataxin gene expansion causes aconitase and mitochondria! iron-sulfur protein deficiency in Friedreich ataxia. Nat Genet. 1997;17:215-217.
64. Wink DA, Nims RW, Desrasiers F, Ford PC, Keefer LF. A kinetic investigation of intermediates formed during the Fenton reagent mediated degradation of N-nitrosodimethylamine: evidence for an oxidative pathway not involving hydroxyl radical. ChemRes Toxicol. 1991;4:510-512.
65. Linseman KL, Larson P, Braughler M, McCall JM. Iron-initiated tissue oxidation: lipid peroxidation, vitamin E destruction and protein thiol oxidation: inhibition by a novel antioxidant, U-78517F. Biochem Pharmacol. 1993:45:1477-1482.
66. Ben Hamida M, Belal S, Sirugo G, et al. Friedreich's ataxia phenotype not linked to chromosome 9 and associated with selective autosomal recessive vitamin E deficiency in too inbred Tunisian families. Neurology. 1993;43:2179-2183.
67. Delatycki MB, Camakaris J, Brooks H, et al. Direct evidence that mitochondrial iron accumulation occurs in Friedreich ataxia. Ann Neurol. 1999:45:673-675.
68. Wong-Riley MT, Kageyama GH. Localization of cytochrome oxidase in the mammalian spinal cord and dorsal root ganglia, with quantitative analysis of ventral horn cells in monkeys. J Comp Neurol. 1986:245:41-61.
69. Ishihara A, Roy RR, Edgerton VR. Succinate dehydrogenase activity and soma size relationship among cat dorsal root ganglion neurons. Brain Res. 1995:676: 212-218.
70. Dun NJ, Dun SL, Wu SY, Forstermann U, Schmidt HH, Tseng LF. Nitric oxide synthase immunoreactivity in the rat, mouse, cat and squirrel monkey spinal cord. Neuroscience. 1993:54:845-857.
71. Ueda F, Raja KB, Simpson RJ, Trowbridge IS, Bradbury MW. Rate of 59Fe uptake into brain and cerebrospinal fluid and the influence thereon of antibodies against the transferrin receptor. JNeurochem. 1993:60:106-113.
72. Connor JR, Menzies SL. Cellular management of iron in the brain. J Neurol Sei. 1995:134:27-32.
73. Szanto J, Gallyas F. A study on iron metabolism in neuropsychiatrie patients. Arch Neurol. 1966:14:442-448.
74. Gerlach M, Ben-Shachar D, Biederer P, Youdim MB. Altered brain metabolism of iron as a cause of neurodegenerative diseases? JNeurochem. 1994:63:793-807.
75. Radisky DC, Babcock MC, Kaplan J. The yeast frataxin homologue mediates mitochondrial iron efflux: evidence for a mitochondiral iron cycle. JBiolChem. 1999; 274:4497-4499.
76. Ponka P, Schulman HM. Regulation of heme biosynthesis: distinct regulatory features in erythroid cells. Stem Cells. 1993;11(suppl 1):24-35.
77. Klockgether T, Ludtke R, Kramer B, et al. The natural history of degenerative ataxia: a retrospective study in 466 patients. Brain. 1998:121:589-600.